BK

Bir Kaman Bishwokarma

Director Director DIN 09252101
DIN 09252101 First appointment Jul 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Bir Kaman Bishwokarma

Data last updated:

Bir Kaman Bishwokarma has 5 years in corporate governance. Formerly with 1 company, such as Medisigma Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09252101
Primary Designation Director
First Appointment 23 Jul 2021
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medisigma Pharma Private Limited U51909MH2021PTC364517
Director23 Jul 20212021₹7.7 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medisigma Pharma Private Limited
Premium access

Shareholding and investment profile for Bir Kaman Bishwokarma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bir Kaman Bishwokarma

Bir Kaman Bishwokarma has 5 years in corporate governance. Formerly with 1 company, such as Medisigma Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Bir Kaman Bishwokarma has expertise in General Business.

Bir Kaman Bishwokarma has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available